Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients

Intensive Care Medicine

Volumn 30, Issue 1, 2004, Pages 45-50

  Johnston, Andrew J ^a   Steiner, Luzius A ^a,b   O'Connell, Mark ^a,b   Chatfield, Dot A ^a   Gupta, Arun K ^a   Menon, David K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Critical care; Dopamine; Intensive care; Norepinephrine; Pharmacodynamics; Pharmacokinetics

Indexed keywords

CATECHOLAMINE; DOPAMINE; NORADRENALIN;

ADULT; ARTICLE; BRAIN PERFUSION; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; DOPAMINE BLOOD LEVEL; DRUG EFFECT; FEMALE; HEAD INJURY; HEART INDEX; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; NORADRENALIN BLOOD LEVEL; PERFUSION PRESSURE; PHARMACODYNAMICS; RANDOMIZATION; STATISTICAL SIGNIFICANCE;

ADULT; CARDIOTONIC AGENTS; CATECHOLAMINES; CRANIOCEREBRAL TRAUMA; CRITICAL ILLNESS; CROSS-OVER STUDIES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL PRESSURE; LINEAR MODELS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0742302656     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-2032-4     Document Type: Article

References (34)

1. Hoffman BB, Lefkowitz RJ (1990) Catecholamines and sympathomimetic drugs. In: Gillman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's the pharmacological basis of therapeutics. Pergamon, New York, pp 187-243
2. Jarnberg PO, Bengtsson L, Ekstrand J, Hamberger B (1981) Dopamine infusion in man. Plasma catecholamine levels and pharmacokinetics. Acta Anaesthesiol Scand 25:328-331
3. MacGregor DA, Smith TE, Prielipp RC, Butterworth JF, James RL, Scuderi PE (2000) Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 92:338-346
4. Banner W Jr, Vernon DD, Dean JM, Swenson E (1989) Nonlinear dopamine pharmacokinetics in pediatric patients. J Pharmacol Exp Ther 249:131-133
5. Kellum JA, J MD (2001) Use of dopamine in acute renal failure: a metaanalysis. Crit Care Med 29:1526-1531
6. Padbury JF, Agata Y, Baylen BG, Ludlow JK, Polk DH, Habib DM, Martinez AM (1990) Pharmacokinetics of dopamine in critically ill newborn infants. J Pediatr 117:472-476
7. Juste RN, Moran L, Hooper J, Soni N (1998) Dopamine clearance in critically ill patients. Intensive Care Med 24:1217-1220
8. Juste RN, Panikkar K, Soni N (1998) The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med 24:564-568
9. Zaritsky A, Lotze A, Stull R, Goldstein DS (1988) Steady-state dopamine clearance in critically ill infants and children. Crit Care Med 16:217-220
10. Eldadah MK, Schwartz PH, Harrison R, Newth CJ (1991) Pharmacokinetics of dopamine in infants and children. Crit Care Med 19:1008-1011
11. Le Corre P, Malledant Y, Tanguy M, Le Verge R (1993) Steady-state pharmacokinetics of dopamine in adult patients. Crit Care Med 21:1652-1657
12. Ratge D, Steegmuller U, Mikus G, Kohse KP, Wisser H (1990) Dopamine infusion in healthy subjects and critically ill patients. Clin Exp Pharmacol Physiol 17:361-369
13. Patel HC, Menon DK, Tebbs S, Hawker R, Hutchinson PJ, Kirkpatrick PJ (2002) Specialist neurocritical care and outcome from head injury. Intensive Care Med 28:547-553
14. Czosnyka M, Whitehouse H, Smielewski P, Kirkpatrick P, Guazzo EP, Pickard JD (1994) Computer-supported multimodal bed-side monitoring for neuro intensive care. Int J Clin Monit Comput 11:223-232
15. Smedes F, Kraak JC, Poppe H (1982) Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr 231:25-39
16. O'Connell MT, Portas CM, Sarna GS, Curzon G (1991) Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo. Br J Pharmacol 102:831-836
17. Johnston AJ, Steiner LA, Chatfield D (2002) The effects of inotropes on brain tissue oxygenation. J Neurosurg Anesthesiol 14: P86
18. Calvey TN, Williams NE (1997) Pharmacokinetics. In: Calvey TN, Williams NE (eds) Principles and practice of pharmacology for anaesthetists. Blackwell Science, Oxford, pp 36-68
19. Garcia-Sainz JA, Vazquez-Prado J, del Carmen Medina L (2000) Alpha 1-adrenoceptors: function and phosphorylation. Eur J Pharmacol 389:1-12
20. Johnston AJ, Gunning KE (2001) The role of corticosteroids in sepsis. Br J Intensive Care Summer:57-62
21. Annane D (2001) Corticosteroids for septic shock. Crit Care Med 29: S117-120
22. Gundert-Remy U, Penzien J, Hildebrandt R, Maurer W, Weber E (1984) Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjects. Eur J Clin Pharmacol 26:163-169
23. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH (2002) Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 114:154-158
24. Norton N, Kirov G, Zammit S, Jones G, Jones S, Owen R, Krawczak M, Williams NM, O'Donovan MC, Owen MJ (2002) Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet 114:491-496
25. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF (2001) A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515-522
26. DeMille MM, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A, Okonofua F, Grigorenko E, Schulz LO, Bonne-Tamir B, Lu RB, Parnas J, Pakstis AJ, Kidd KK (2002) Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 111:521-537
27. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM (1997) High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74:439-442
28. Sabol SZ, Hu S, Hamer D (1998) A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279
29. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, Harrington R, McGuffin P, O'Donovan M, Owen M, Ollier W, Worthington J, Thapar A (2001) Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet 105:464-470
30. de la Cal MA, Miravalles E, Pascual T, Esteban A, Ruiz-Santana S (1984) Dose-related hemodynamic and renal effects of dopamine in septic shock. Crit Care Med 12:22-25
31. Miall-Allen VM, Whitelaw AG (1989) Response to dopamine and dobutamine in the preterm infant less than 30 weeks gestation. Crit Care Med 17:1166-1169
32. Booker PD, Evans C, Franks R (1995) Comparison of the haemodynamic effects of dopamine and dobutamine in young children undergoing cardiac surgery. Br J Anaesth 74:419-423
33. Meier-Hellmann A, Bredle DL, Specht M, Spies C, Hannemann L, Reinhart K (1997) The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 23:31-37
34. Day NP, Phu NH, Mai NT, Bethell DB, Chau TT, Loc PP, Chuong LV, Sinh DX, Solomon T, Haywood G, Hien TT, White NJ (2000) Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis. Crit Care Med 28:1353-1362